| Product Code: ETC12463378 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Japan Imatinib Drug Market Overview |
3.1 Japan Country Macro Economic Indicators |
3.2 Japan Imatinib Drug Market Revenues & Volume, 2021 & 2031F |
3.3 Japan Imatinib Drug Market - Industry Life Cycle |
3.4 Japan Imatinib Drug Market - Porter's Five Forces |
3.5 Japan Imatinib Drug Market Revenues & Volume Share, By Drug Form, 2021 & 2031F |
3.6 Japan Imatinib Drug Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Japan Imatinib Drug Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 Japan Imatinib Drug Market Revenues & Volume Share, By Sales Channel, 2021 & 2031F |
3.9 Japan Imatinib Drug Market Revenues & Volume Share, By Mode of Administration, 2021 & 2031F |
4 Japan Imatinib Drug Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GIST) in Japan |
4.2.2 Growing awareness about targeted cancer therapies among healthcare professionals and patients |
4.2.3 Favorable government policies and regulations supporting access to innovative cancer treatments |
4.3 Market Restraints |
4.3.1 High cost associated with imatinib therapy leading to affordability issues for some patients |
4.3.2 Generic competition impacting the pricing and profitability of branded imatinib drugs |
4.3.3 Stringent regulatory requirements for drug approval and market entry potentially delaying product launches |
5 Japan Imatinib Drug Market Trends |
6 Japan Imatinib Drug Market, By Types |
6.1 Japan Imatinib Drug Market, By Drug Form |
6.1.1 Overview and Analysis |
6.1.2 Japan Imatinib Drug Market Revenues & Volume, By Drug Form, 2021 - 2031F |
6.1.3 Japan Imatinib Drug Market Revenues & Volume, By Tablets, 2021 - 2031F |
6.1.4 Japan Imatinib Drug Market Revenues & Volume, By Capsules, 2021 - 2031F |
6.1.5 Japan Imatinib Drug Market Revenues & Volume, By Powder Form, 2021 - 2031F |
6.1.6 Japan Imatinib Drug Market Revenues & Volume, By Liquid Form, 2021 - 2031F |
6.1.7 Japan Imatinib Drug Market Revenues & Volume, By Extended Release Tablets, 2021 - 2031F |
6.2 Japan Imatinib Drug Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Japan Imatinib Drug Market Revenues & Volume, By Leukemia Treatment, 2021 - 2031F |
6.2.3 Japan Imatinib Drug Market Revenues & Volume, By Gastrointestinal Stromal Tumors, 2021 - 2031F |
6.2.4 Japan Imatinib Drug Market Revenues & Volume, By Chronic Myeloid Leukemia, 2021 - 2031F |
6.2.5 Japan Imatinib Drug Market Revenues & Volume, By Breast Cancer Treatment, 2021 - 2031F |
6.2.6 Japan Imatinib Drug Market Revenues & Volume, By Rare Tumor Management, 2021 - 2031F |
6.3 Japan Imatinib Drug Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Japan Imatinib Drug Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.3 Japan Imatinib Drug Market Revenues & Volume, By Cancer Research Centers, 2021 - 2031F |
6.3.4 Japan Imatinib Drug Market Revenues & Volume, By Specialty Clinics, 2021 - 2031F |
6.3.5 Japan Imatinib Drug Market Revenues & Volume, By Pharmaceutical Companies, 2021 - 2031F |
6.3.6 Japan Imatinib Drug Market Revenues & Volume, By Government Healthcare Units, 2021 - 2031F |
6.4 Japan Imatinib Drug Market, By Sales Channel |
6.4.1 Overview and Analysis |
6.4.2 Japan Imatinib Drug Market Revenues & Volume, By Direct Procurement, 2021 - 2031F |
6.4.3 Japan Imatinib Drug Market Revenues & Volume, By Distributors, 2021 - 2031F |
6.4.4 Japan Imatinib Drug Market Revenues & Volume, By Online Pharmacies, 2021 - 2031F |
6.4.5 Japan Imatinib Drug Market Revenues & Volume, By Hospital Pharmacies, 2021 - 2031F |
6.4.6 Japan Imatinib Drug Market Revenues & Volume, By Retail Pharmacies, 2021 - 2031F |
6.5 Japan Imatinib Drug Market, By Mode of Administration |
6.5.1 Overview and Analysis |
6.5.2 Japan Imatinib Drug Market Revenues & Volume, By Oral Administration, 2021 - 2031F |
6.5.3 Japan Imatinib Drug Market Revenues & Volume, By Injection Therapy, 2021 - 2031F |
6.5.4 Japan Imatinib Drug Market Revenues & Volume, By Infusion Therapy, 2021 - 2031F |
6.5.5 Japan Imatinib Drug Market Revenues & Volume, By Combination Therapy, 2021 - 2031F |
6.5.6 Japan Imatinib Drug Market Revenues & Volume, By Targeted Therapy, 2021 - 2031F |
7 Japan Imatinib Drug Market Import-Export Trade Statistics |
7.1 Japan Imatinib Drug Market Export to Major Countries |
7.2 Japan Imatinib Drug Market Imports from Major Countries |
8 Japan Imatinib Drug Market Key Performance Indicators |
8.1 Patient adherence rate to imatinib treatment |
8.2 Number of healthcare facilities offering imatinib therapy |
8.3 Rate of adoption of personalized medicine approaches in cancer treatment |
8.4 Average time to market approval for new imatinib formulations |
8.5 Number of clinical trials evaluating the efficacy and safety of imatinib in different cancer indications |
9 Japan Imatinib Drug Market - Opportunity Assessment |
9.1 Japan Imatinib Drug Market Opportunity Assessment, By Drug Form, 2021 & 2031F |
9.2 Japan Imatinib Drug Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Japan Imatinib Drug Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 Japan Imatinib Drug Market Opportunity Assessment, By Sales Channel, 2021 & 2031F |
9.5 Japan Imatinib Drug Market Opportunity Assessment, By Mode of Administration, 2021 & 2031F |
10 Japan Imatinib Drug Market - Competitive Landscape |
10.1 Japan Imatinib Drug Market Revenue Share, By Companies, 2024 |
10.2 Japan Imatinib Drug Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here